Gsk (GSK) Shares Outstanding (Weighted Average) (2009 - 2026)
Gsk (GSK) posted Shares Outstanding (Weighted Average) of $1.8 billion for Q4 2025, down 65.71% on a QoQ basis from $5.2 billion in Q4 2024, and down 65.71% year-over-year from $5.2 billion in Q4 2024.
Gsk (GSK) has 11 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.8 billion in Q4 2025.
- In Q4 2025, Shares Outstanding (Weighted Average) fell 65.71% year-over-year to $1.8 billion; the TTM figure through Dec 2025 stood at $1.8 billion (down 65.71% YoY), while the FY2025 annual figure was $1.8 billion, down 65.71% from the prior year.
- Shares Outstanding (Weighted Average) retreated to $1.8 billion in Q4 2025, from $5.2 billion in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $5.4 billion in Q4 2021 and bottomed at $1.8 billion in Q4 2025.
- A 5-year average of $4.4 billion and a median of $5.0 billion in 2023 frame the typical range for Shares Outstanding (Weighted Average).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) advanced 6.5% — and 2025, when it slumped 65.71%.
- Year by year, Shares Outstanding (Weighted Average) stood at $5.4 billion in 2021, then dropped by 12.49% to $4.7 billion in 2022, then increased by 6.5% to $5.0 billion in 2023, then gained by 4.05% to $5.2 billion in 2024, then slumped by 65.71% to $1.8 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1.8 billion (Q4 2025), $5.2 billion (Q4 2024), and $5.0 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 736,000.00 Bn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 894.50 Mn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 2.41 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.47 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.24 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 5.69 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.04 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 1.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,818,692.66 Bn |
| Dec 31, 2025 | 1,794,394.20 Bn |
| Sep 30, 2025 | 1,820,289.54 Bn |
| Jun 30, 2025 | 1,799,627.63 Bn |
| Mar 31, 2025 | 1,699,066.23 Bn |
| Dec 31, 2024 | 1.73 Bn |
| Sep 30, 2024 | 1,751,456.62 Bn |
| Jun 30, 2024 | 1,701,473.57 Bn |
| Mar 31, 2024 | 1,709,962.51 Bn |
| Dec 31, 2023 | 5.03 Bn |
| Sep 30, 2023 | 1,707,491.10 Bn |
| Jun 30, 2023 | 1,686,837.53 Bn |
| Mar 31, 2023 | 4,915,520.50 Bn |
| Dec 31, 2022 | 4.72 Bn |
| Sep 30, 2022 | 1,587,504.55 Bn |
| Jun 30, 2022 | 1,696,296.23 Bn |
| Mar 31, 2022 | 1,807,452.69 Bn |
| Dec 31, 2021 | 5.40 Bn |
| Sep 30, 2021 | 1,856,951.77 Bn |
| Jun 30, 2021 | 1,882,739.96 Bn |
| Mar 31, 2021 | 1,856,027.36 Bn |
| Dec 31, 2020 | 5.26 Bn |
| Jun 30, 2020 | 1,671,322.27 Bn |
| Mar 31, 2020 | 1,725,390.31 Bn |
| Dec 31, 2019 | 6.36 Bn |
| Sep 30, 2019 | 1,658,726.04 Bn |
| Jun 30, 2019 | 1,730,090.47 Bn |
| Mar 31, 2019 | 1,751,019.40 Bn |
| Dec 31, 2018 | 6.32 Bn |
| Sep 30, 2018 | 1,751,840.76 Bn |
| Jun 30, 2018 | 1,829,642.56 Bn |
| Mar 31, 2018 | 15.58 Bn |
| Dec 31, 2017 | 6.49 Bn |
| Sep 30, 2017 | 1,757,370.11 Bn |
| Jun 30, 2017 | 1,716,099.62 Bn |
| Mar 31, 2017 | 26,509.20 Bn |
| Dec 31, 2016 | 6.04 Bn |
| Sep 30, 2016 | 1,762,860.53 Bn |
| Jun 30, 2016 | 1,925,940.75 Bn |
| Mar 31, 2016 | 1,920,605.86 Bn |
| Dec 31, 2015 | 7.33 Bn |
| Sep 30, 2015 | 2,077,619.28 Bn |
| Jun 30, 2015 | 2,049,489.51 Bn |
| Mar 31, 2015 | 2,030,842.31 Bn |
| Dec 31, 2014 | 2,121,515.76 Bn |
| Sep 30, 2014 | 2,236,612.66 Bn |
| Jun 30, 2014 | 2,251,358.26 Bn |
| Mar 31, 2014 | 2,212,469.31 Bn |
| Dec 31, 2013 | 2,163,081.88 Bn |
| Sep 30, 2013 | 2,078,530.09 Bn |
| Jun 30, 2013 | 2,077,945.78 Bn |
| Mar 31, 2013 | 2,101,888.63 Bn |
| Dec 31, 2012 | 2,166,318.42 Bn |
| Sep 30, 2012 | 2,149,215.60 Bn |
| Jun 30, 2012 | 2,164,720.33 Bn |
| Mar 31, 2012 | 2,183,829.41 Bn |
| Dec 31, 2011 | 2,179,763.38 Bn |
| Sep 30, 2011 | 2,241,672.22 Bn |
| Jun 30, 2011 | 2,282,742.87 Bn |
| Mar 31, 2011 | 2,267,541.06 Bn |
| Dec 31, 2010 | 2,240,262.81 Bn |
| Sep 30, 2010 | 2,197,055.22 Bn |
| Jun 30, 2010 | 2,115,105.39 Bn |
| Mar 31, 2010 | 2,211,616.21 Bn |
| Dec 31, 2009 | 2,313,004.67 Bn |
| Sep 30, 2009 | 2,323,373.24 Bn |
| Jun 30, 2009 | 2,192,673.03 Bn |
| Mar 31, 2009 | 37.79 Bn |